M. Demiray Et Al. , "Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients," Turkish Journal of Cancer , vol.35, no.4, pp.159-165, 2005
Demiray, M. Et Al. 2005. Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients. Turkish Journal of Cancer , vol.35, no.4 , 159-165.
Demiray, M., EVRENSEL, T., ARSLAN, M., Kanat, Ö., Kurt, E., SARAYDAROĞLU, Ö., ... ERCAN, İ.(2005). Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients. Turkish Journal of Cancer , vol.35, no.4, 159-165.
Demiray, Mutlu Et Al. "Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients," Turkish Journal of Cancer , vol.35, no.4, 159-165, 2005
Demiray, Mutlu Et Al. "Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients." Turkish Journal of Cancer , vol.35, no.4, pp.159-165, 2005
Demiray, M. Et Al. (2005) . "Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients." Turkish Journal of Cancer , vol.35, no.4, pp.159-165.
@article{article, author={Mutlu Demiray Et Al. }, title={Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients}, journal={Turkish Journal of Cancer}, year=2005, pages={159-165} }